Halozyme Therapeutics shares owned by Hussman Econometrics Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Hussman Econometrics Advisors
from 13F filings
Historical chart of Hussman Econometrics Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Hussman Econometrics Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Hussman Econometrics Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $3.5M | 74k | 47.81 |
| 2024-09-30 | $2.4M | 42k | 57.24 |
| 2024-06-30 | $2.2M | 42k | 52.36 |
| 2024-03-31 | $1.3M | 32k | 40.68 |
| 2023-12-31 | $1.2M | 32k | 36.96 |
| 2023-09-30 | $1.2M | 32k | 38.20 |
| 2023-06-30 | $1.7M | 47k | 36.07 |
| 2023-03-31 | $1.8M | 47k | 38.19 |
| 2022-12-31 | $1.4M | 25k | 56.90 |
| 2022-09-30 | $1.2M | 31k | 39.55 |
| 2022-06-30 | $409k | 9.3k | 43.98 |
More positions owned by Hussman Econometrics Advisors
View all positions for Hussman Econometrics Advisors